Completed NA INTERVENTIONAL 2-arm NCT06294756

Sulfureous Water Therapy in Viral Respiratory Diseases (STWandRVD)

Effects of Sulfurous Thermal Waters Inhalations on Long-COVID Syndrome: a Double-blinded, Interventional, Randomized Case-control, Pilot Study on a Spa Centered Rehab Program

Sponsor: Bios Prevention Srl

Conditions Chronic COVID-19 Syndrome Long-COVID Post Acute Sequelae of COVID-19 Post COVID-19 Condition

Interventions Inhalation of Sterile Distilled non-pyrogenic Water Inhalation of Sulfurous Thermal Water

Updated 3 times since 2024 Last updated: Mar 2, 2024 Started: May 30, 2023 Primary completion: Aug 1, 2023 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Chronic COVID-19 Syndrome and Long-COVID and is currently completed. Bios Prevention Srl leads this study, which shows 3 recorded versions since 2023 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2024 — Jul 2024 [monthly]

Completed NA

First recorded

May 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bios Prevention Srl
Queen Mary University of London
University of Roma La Sapienza
Università degli studi di Roma Foro Italico

Data source: University of Roma La Sapienza

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tivoli, Italy